{"id":"W2590078033","doi":"10.1182/blood.v114.22.1661.1661","title":"The VcR-CVAD Regimen Produces a High Complete Response Rate in Untreated Mantle Cell Lymphoma (MCL): First Analysis of E1405 – A Phase II Study of VcR-CVAD with Maintenance Rituximab for MCL.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Regimen; Mantle cell lymphoma; Vincristine; Rituximab; Bortezomib; Cyclophosphamide; Internal medicine; Surgery; Chemotherapy; Chemotherapy regimen; Phases of clinical research; Gastroenterology; Urology; Lymphoma; Multiple myeloma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002862523,0.0006825455,0.001288027,0.0005413528,0.0003410337,0.0008623723,0.001067832,0.001045123,0.001831137],"category_scores_gemma":[0.001036673,0.0004462294,0.0007763895,0.0003867871,0.0007089971,0.0006072909,0.0003428622,0.001895532,0.0004960197],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009152544,"about_ca_system_score_gemma":0.0007422263,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001087754,"about_ca_topic_score_gemma":0.002166101,"domain_scores_codex":[0.9988186,0.0005881275,0.00007771005,0.0001754576,0.0001611694,0.0001788611],"domain_scores_gemma":[0.9991632,0.0002224181,0.0001221736,0.0001137952,0.00004820093,0.0003302208],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2819536,0.163972,0.04015221,0.0007002148,0.001859882,0.000876,0.0009557211,0.0049555,0.2082741,0.0007351388,0.003865156,0.2917006],"study_design_scores_gemma":[0.0846114,0.8406869,0.04817991,0.00003294771,0.0003659195,0.0008427289,0.00008349308,0.002131159,0.01941505,0.0001220149,0.003484945,0.00004343999],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972416,0.0007382783,0.0003348306,0.00007896973,0.00001449767,0.0005392604,0.000243051,0.00003511755,0.0007744184],"genre_scores_gemma":[0.9964427,0.0003330124,0.001024542,0.000178082,0.00004190631,0.0002639364,0.0008983177,0.00001291753,0.0008045463],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002862523,"threshold_uncertainty_score":0.01513869,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01270443822665775,"score_gpt":0.2603393007549339,"score_spread":0.2476348625282761,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}